BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 16717405)

  • 1. Antibiotic resistance in bacteria and its future for novel antibiotic development.
    Yoneyama H; Katsumata R
    Biosci Biotechnol Biochem; 2006 May; 70(5):1060-75. PubMed ID: 16717405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial targets to antimicrobial leads and development candidates.
    Rogers BL
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics in the clinical pipeline in 2011.
    Butler MS; Cooper MA
    J Antibiot (Tokyo); 2011 Jun; 64(6):413-25. PubMed ID: 21587262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future challenges facing the development of new antimicrobial drugs.
    Coates A; Hu Y; Bax R; Page C
    Nat Rev Drug Discov; 2002 Nov; 1(11):895-910. PubMed ID: 12415249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting genomics, genetics and chemistry to combat antibiotic resistance.
    Hughes D
    Nat Rev Genet; 2003 Jun; 4(6):432-41. PubMed ID: 12776213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel systemic antibiotics in dermatology.
    Atanaskova Mesinkovska N; Tomecki KJ
    Dermatol Ther; 2012; 25(1):1-5. PubMed ID: 22591494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial resistance and study of new antibiotics].
    Xiao CL; Yao TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):351-3. PubMed ID: 15379254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
    Bragonzi A
    Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ
    Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics in development targeting protein synthesis.
    Sutcliffe JA
    Ann N Y Acad Sci; 2011 Dec; 1241():122-52. PubMed ID: 22191530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small and lethal: searching for new antibacterial compounds with novel modes of action.
    Pathania R; Brown ED
    Biochem Cell Biol; 2008 Apr; 86(2):111-5. PubMed ID: 18443624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products--the future scaffolds for novel antibiotics?
    Butler MS; Buss AD
    Biochem Pharmacol; 2006 Mar; 71(7):919-29. PubMed ID: 16289393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
    Lynch AS
    Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic diastereomeric-antimicrobial peptide: antibacterial activity against multiple drug resistant clinical isolates.
    Park SC; Kim JY; Lee JK; Yoo S; Kim H; Seo CH; Nah JW; Hahm KS; Park Y
    Biopolymers; 2011; 96(2):130-6. PubMed ID: 20564032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Classes of Antibacterial Drugs in Clinical Development, a Hope in a Post-antibiotic Era.
    Campanini-Salinas J; Andrades-Lagos J; Mella-Raipan J; Vasquez-Velasquez D
    Curr Top Med Chem; 2018; 18(14):1188-1202. PubMed ID: 30117393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.